Immune-Related Biomarkers in Cancer: Development, Validation, and Challenges in Clinical Practice—A Systematic Review
Cancer Immuno Perspectives · 01.09.2025
DOI: 10.70996/cip.00002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Immuno Perspectives, online erschienen am 01.09.2025. Verfasst von Yu Liu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Cancer immunotherapy, particularly immune checkpoint inhibitors (ICIs), has fundamentally transformed oncology treatment over the past decade, markedly improving survival across multiple tumor types. However, response rates remain limited, with only 15-30% of patients deriving clinical benefit, highlighting the critical need for reliable predictive biomarkers. This systematic review comprehensively examines the current landscape of immune-related biomarkers in cancer, focusing on their development, validation methodologies, and challenges in clinical translation. We analyze biomarker categories including tumor microenvironment-based markers (PD-L1, TMB), peripheral blood markers (autoantibodies, inflammatory indices), and emerging multi-omics approaches. The review further explores the complex validation pathway for clinical implementation, addressing persistent obstacles such as tumor heterogeneity, technical standardization, and biological complexity. Finally, we discuss innovative strategies and future directions aimed at enhancing biomarker performance through multi-omics integration, artificial intelligence, and novel trial designs. The continued evolution of biomarker development holds significant promise for advancing precision immuno-oncology and optimizing patient outcomes.
Zitieren
APA
Liu, Y., & Li, L. (2025). Immune-Related Biomarkers in Cancer: Development, Validation, and Challenges in Clinical Practice—A Systematic Review. Cancer Immuno Perspectives. https://doi.org/10.70996/cip.00002
Vancouver
Liu Y, Li L. Immune-Related Biomarkers in Cancer: Development, Validation, and Challenges in Clinical Practice—A Systematic Review. Cancer Immuno Perspectives. 2025. doi:10.70996/cip.00002
BibTeX
@article{Liu2025,
author = {Liu, Yu and Li, Liang},
title = {Immune-Related Biomarkers in Cancer: Development, Validation, and Challenges in Clinical Practice—A Systematic Review},
journal = {Cancer Immuno Perspectives},
year = {2025},
doi = {10.70996/cip.00002}
}
EUVIMED